Cargando…
Advances in identification and selection of personalized neoantigen/T-cell pairs for autologous adoptive T cell therapies
Based on the success of tumor-infiltrating lymphocytes (TIL)-based therapies, personalized adoptive cell therapies (ACT) targeting neoantigens have the potential to become a disruptive technology and lead to highly effective treatments for cancer patients for whom no other options exist. ACT of TIL,...
Autores principales: | Kast, Florian, Klein, Christian, Umaña, Pablo, Gros, Alena, Gasser, Stephan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808433/ https://www.ncbi.nlm.nih.gov/pubmed/33520408 http://dx.doi.org/10.1080/2162402X.2020.1869389 |
Ejemplares similares
-
Determinants for Neoantigen Identification
por: Garcia-Garijo, Andrea, et al.
Publicado: (2019) -
Neoantigen-Specific Adoptive Cell Therapies for Cancer: Making T-Cell Products More Personal
por: Bianchi, Valentina, et al.
Publicado: (2020) -
Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation
por: Seliktar-Ofir, Sivan, et al.
Publicado: (2017) -
Neoantigen‐reactive T cell: An emerging role in adoptive cellular immunotherapy
por: Zhu, Yicheng, et al.
Publicado: (2021) -
Personalized neoantigen pulsed dendritic cell vaccine for advanced lung cancer
por: Ding, Zhenyu, et al.
Publicado: (2021)